FOUND 6
This research paper describes the particular vulnerability of women living with HIV in the context of armed conflicts. Disruption to regular testing, treatment regimens, and SRHR services plays a significant role in the worsened health outcomes experienced by WLHIV during conflicts.
Women living with HIV experience disproportionate and alarming rates of coercive practices, mistreatment, and abuse particularly while exercising their sexual and reproductive health and rights. This report seeks to understand women living with HIV's experiences of these human rights violations, highlighting stories from women in over 60 countries, and identifying the persistent and widespread nature of this problem.
This review aims to synthesize existing evidence of the mental health burden on women living with HIV/AIDS in sub-Saharan Africa. It explores the contributing stressors, protective factors, and effects of mental illness on viral suppression rates, providing a clear argument for the integration of increased mental health care services in the HIV response.
Psychosocial factors were independent atherosclerotic risk factors among Women Living With HIV (WLWH). Research is needed to determine whether interventions for depression and psychosocial stress can mitigate the increased risk of atherosclerosis for WLWH.
UNAIDS report on the global AIDS pandemic 2020  shows that women and girls in sub-Saharan Africa continue to be the most affected and accounted for 59% of all new HIV infections in the region in 2019, with 4500 adolescent girls and young women between 15 and 24 years old becoming infected with HIV every week. Young women accounted for 24% of new HIV infections in 2019, despite making up only 10% of the population in sub-Saharan Africa. 
In alignment with the United States President’s Emergency Plan for AIDS Relief (PEPFAR) goal to reach ‘95-95-95’ targets – that 95 percent of all people living with HIV will know their status, 95 percent of all those with diagnosed HIV infection will receive sustained antiretroviral therapy (ART), and 95 percent of all those receiving ART will have viral suppression by 2020 – a gender analysis is an important planning tool for the development of…